Media Center

 

Third Rock News & Events

January 26, 2017 - Third Rock Ventures Names Sarah Larson as Partner
» Read More

October 31, 2016 - Third Rock Ventures Raises $616 Million Fund IV
» Read More

September 24, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to receive the Henri Termeer Lifetime Achievement Award at the 5th Annual Tribute to Champions of Hope
» Read More

May 23, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to Speak at MassBio Event to Discuss his New Book “Orphan: The Quest to Save Children with Rare Disease”
» Read More

April 25, 2016 - Third Rock Ventures' Partner, Robert Tepper, to Moderate Panel at the World Medical Innovation Forum
» Read More

April 6, 2016 - Third Rock Ventures' Partner, Cary Pfeffer, to Present at Xconomy's EXOME: What's Hot in Boston Biotech
» Read More

Portfolio News

Foundation Medicine
July 12, 2017 - Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call
» Press Release | Company News

Global Blood Therapeutics
July 10, 2017 - Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population
» Press Release | Company News

Neon Therapeutics
July 10, 2017 - CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration
» Press Release | Company News

SAGE Therapeutics
July 10, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Decibel Therapeutics
July 6, 2017 - Decibel Therapeutics Announces Investment from GV to Expand Capabilities for Biological Target Identification in Hearing Loss and Tinnitus
» Press Release | Company News

Neon Therapeutics
July 5, 2017 - Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature
» Press Release | Company News

CytomX Therapeutics
June 29, 2017 - CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate
» Press Release | Company News

CytomX Therapeutics
June 28, 2017 - CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial
» Press Release | Company News

Global Blood Therapeutics
June 28, 2017 - Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)
» Press Release | Company News

bluebird bio
June 27, 2017 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

News Archives